Form 8-K - Current report:
SEC Accession No. 0001214659-23-003460
Filing Date
2023-03-02
Accepted
2023-03-02 17:15:20
Documents
12
Period of Report
2023-03-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 b322318k.htm   iXBRL 8-K 24857
  Complete submission text file 0001214659-23-003460.txt   196938

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hgen-20230302.xsd EX-101.SCH 3203
3 XBRL LABEL FILE hgen-20230302_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE hgen-20230302_pre.xml EX-101.PRE 22343
6 EXTRACTED XBRL INSTANCE DOCUMENT b322318k_htm.xml XML 3571
Mailing Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078
Business Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078 (973) 200-3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 23700254
SIC: 2834 Pharmaceutical Preparations